| Cvs Pharmacy # 04608 | |
| 24800 S Tamiami Trl, Bonita Springs, Florida 34134 | |
| (239) 947-6999 |
| Name | Cvs Pharmacy # 04608 |
|---|---|
| Organization Name | Holiday Cvs Llc |
| Location | 24800 S Tamiami Trl, Bonita Springs, Florida 34134 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (239) 947-6999 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Regado Biosciences, a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, announced that on September 8, 2009 enrollment of the first patient in a Phase 2b, randomized, partially-blinded, multi-center, active-controlled, dose-ranging study of its lead product candidate, the REG1 anticoagulation system (REG1) was achieved.
Envoy Therapeutics, a drug discovery company, today announced that it has reached a milestone in its strategic alliance with Merck.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
In today's highly competitive marketplace, bio-pharmaceutical companies often look to expand their product portfolios in the same indication. This "double-dipping" can result in a new brand gaining more profitability at the expense of a more established brand.
› Verified 2 days ago
| NPI Number | 1386748259 |
| Organization Name | HOLIDAY CVS LLC |
| Doing Business As | CVS PHARMACY #04608 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 24800 S Tamiami Trl, Bonita Springs, FL 34134 |
| Phone Number | 239-947-6999 |
News Archive
Regado Biosciences, a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, announced that on September 8, 2009 enrollment of the first patient in a Phase 2b, randomized, partially-blinded, multi-center, active-controlled, dose-ranging study of its lead product candidate, the REG1 anticoagulation system (REG1) was achieved.
Envoy Therapeutics, a drug discovery company, today announced that it has reached a milestone in its strategic alliance with Merck.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
In today's highly competitive marketplace, bio-pharmaceutical companies often look to expand their product portfolios in the same indication. This "double-dipping" can result in a new brand gaining more profitability at the expense of a more established brand.
› Verified 2 days ago
News Archive
Regado Biosciences, a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, announced that on September 8, 2009 enrollment of the first patient in a Phase 2b, randomized, partially-blinded, multi-center, active-controlled, dose-ranging study of its lead product candidate, the REG1 anticoagulation system (REG1) was achieved.
Envoy Therapeutics, a drug discovery company, today announced that it has reached a milestone in its strategic alliance with Merck.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
In today's highly competitive marketplace, bio-pharmaceutical companies often look to expand their product portfolios in the same indication. This "double-dipping" can result in a new brand gaining more profitability at the expense of a more established brand.
› Verified 2 days ago
Publix Pharmacy #1325 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 26841 S Tamiami Trl, Bonita Springs, Florida 34134 Phone: (239) 992-1675 | |
Cvs Pharmacy # 03552 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 27841 Crown Lake Blvd, Bonita Springs, Florida 34135 Phone: (239) 992-2130 | |
Publix Pharmacy #1449 Type: Pharmacy Location: 3304 Bonita Beach Rd, Bonita Springs, Florida 34134 Phone: (239) 495-1700 | |
Publix Pharmacy 0843 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 12900 Trade Way Four, Bonita Springs, Florida 34135 Phone: (239) 992-7508 | |
Cvs Pharmacy # 04608 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 24800 S Tamiami Trl, Bonita Springs, Florida 34134 Phone: (239) 947-6999 |